Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry

Cristina Sottani, Roberta Turci, Luigi Perbellini, Claudio Minoia

Research output: Contribution to journalArticlepeer-review

Abstract

A sensitive, specific and accurate high performance liquid chromatography/ionspray-tandem mass spectrometry procedure (HPLC/MS/MS) has been developed to quantify cyclophosphamide in human urine from hospital personnel involved in drug preparation and administration of antineoplastic alkylating agents. This methodology, which includes liquid-liquid extraction with ethylacetate, requires no derivatization procedures, preventing cyclophosphamide (CP) from possible thermal and chemical decomposition reactions. We detected the excretion of this unmetabolized alkylating drug in 50% of all the study participants. The amount of CP ranged from 0.1 ng mL-1 to 1.9 ng mL-1 urine. This methodology was validated by the use of ifosfamide as internal standard. The assay was linear over the range 0 to 3.2 ng mL-1 urine, with a lower limit of quantification of 0.2 ng mL-1. The limit of detection was assessed at 0.05 ng mL-1 urine. This method is characterized by a coefficient of variation -1) was always more than 85%. The extraction efficiency of cyclophosphamide from urine samples was also studied at six different pH values (pH 4, 5, 6, 7, 8, 10). The maximum extraction efficiency was obtained when the pH of urine solutions was adjusted to 7.0.

Original languageEnglish
Pages (from-to)1063-1068
Number of pages6
JournalRapid Communications in Mass Spectrometry
Volume12
Issue number16
Publication statusPublished - 1998

ASJC Scopus subject areas

  • Analytical Chemistry
  • Spectroscopy

Fingerprint Dive into the research topics of 'Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry'. Together they form a unique fingerprint.

Cite this